Summary & Overview
Other Circulatory System O.R. Procedures: Inpatient Reimbursement Overview
DRG 264 encompasses a range of operative procedures on the circulatory system not captured by more specific cardiac or vascular groupings; it includes thoracic and peripheral circulatory operations that require operating room care. Correct assignment of this Diagnosis-Related Group matters for inpatient reimbursement because it determines bundled Medicare payments tied to procedure complexity and resource consumption.
DRG 264 Overview
DRG 264 covers inpatient cases involving other circulatory system operations performed in the operating room that are not classified under more specific cardiac or vascular procedure groups. Typical cases include assorted thoracic and peripheral circulatory surgical interventions that require significant operating room resources and postoperative inpatient care. This Diagnosis-Related Group is important for Medicare payment because it groups clinically similar procedures to determine bundled reimbursement reflective of resource use. Accurate DRG assignment affects hospital payment and reporting under Centers for Medicare & Medicaid Services inpatient prospective payment policies.
Clinical Trials
- Studies of perioperative and intraoperative techniques to reduce cardiac and vascular complication rates: randomized or prospective cohort trials comparing specific operative strategies (for example, procedural approaches, anesthesia management protocols, or blood management techniques) in patients undergoing non-coronary open or endovascular circulatory system operations grouped under this DRG. These trials enroll adults undergoing complex vascular or cardiac-related O.R. procedures that are not CABG or major valve replacement, assessing endpoints such as perioperative myocardial injury, bleeding, transfusion requirements, and 30-day morbidity. Results inform surgical teams and hospital administrators about interventions that can shorten length of stay, reduce readmissions and complications, and thus impact inpatient resource utilization and reimbursement under this DRG.
- Comparative effectiveness research evaluating device selection and procedural approach in endovascular versus open repair for peripheral or thoracic vascular lesions: observational registries or pragmatic randomized trials that compare short- and mid-term outcomes for different stent-grafts, graft materials, or hybrid techniques in patients treated for non-coronary vascular pathology. These studies focus on patient subgroups commonly billed to this DRG (for example, aneurysm or arterial occlusive disease procedures outside major cardiac surgery) to measure reintervention rates, limb salvage, and hospital-level costs. Findings are relevant to payers and providers because device choice and approach drive index hospitalization costs, downstream procedures, and bundled payment performance.
- Post-discharge outcomes and care-transition trials targeting functional recovery and readmission prevention after complex circulatory O.R. procedures: prospective studies testing structured discharge planning, remote monitoring, medication reconciliation, and rehabilitation pathways in patients discharged after other circulatory system operations. These trials enroll heterogeneous surgical patients captured by this DRG to evaluate 30- and 90-day readmissions, medication adherence, wound complications, and patient-reported functional status. Evidence from these studies helps hospitals optimize discharge practices, reduce penalties from readmissions, and align post-acute care strategies with reimbursement and quality metrics tied to this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.